Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2797671000168114 | HDP (Radpharm) (sodium oxidronate 3.15 mg) powder for injection, 10 x 3.15 mg vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2797681000168112 | HDP (Radpharm) 3.15 mg powder for injection, 10 vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| HDP (Radpharm) 3.15 mg powder for injection, 10 vials | Is a | sodium oxidronate 3.15 mg injection, 10 vials | true | Inferred relationship | Some | ||
| HDP (Radpharm) 3.15 mg powder for injection, 10 vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| HDP (Radpharm) 3.15 mg powder for injection, 10 vials | has TPUU | HDP (Radpharm) 3.15 mg powder for injection, 3.15 mg vial | true | Inferred relationship | Some | 1 | |
| HDP (Radpharm) 3.15 mg powder for injection, 10 vials | has TP | HDP (Radpharm) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| HDP (Radpharm) 3.15 mg powder for injection, 10 vials | Is a | True | HDP (Radpharm) 3.15 mg powder for injection, 10 vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR